Photo of Thomas G. DeLoughery, MD, MACP, FAWM

Thomas G. DeLoughery MD, MACP, FAWM

Tom DeLoughery is a native Hoosier who graduated from Indiana State University in 1981 (one year after Larry Bird) and the Indiana University School of Medicine in 1985. He did his internship at the University of California, Irvine before traveling to Oregon where he finished his internal medicine residency and hematology/oncology fellowship.

He is currently a professor of medicine, pathology and pediatrics in the Divisions of Hematology/Oncology and Laboratory Medicine at OHSU. His clinical interests are in blood diseases, hemostasis, and thrombosis, subjects on which he has written extensively. He has won numerous teaching awards and has given education sessions to national meetings of many professional societies. He is the course director for the medical school Blood Course and was a co-developer of the Blood and Host Defense course for the New Curriculum.

He also has an interest in the hematologic aspects of sport and travel medicine and served six years on the board of directors of the Wilderness Medicine Society and has chaired their research committee. He is a master at the American College of Physicians and Fellows of the Academy of Wilderness Medicine. This year the 3rd edition of his popular handbook Hemostasis and Thrombosis was published.

Read more


  • M.D., Indiana University School of Medicine, Indianapolis Indiana 1985
  • Residency:

    • Oregon Health & Science University, Portland, 1986-88
  • Fellowship:

    • Oregon Health & Science University, Portland, 1989-91
  • Certifications:

    • American Board of Internal Medicine, internal medicine (1988)

Memberships and associations

  • American Association of Blood Bankers


  • "Antithrombotic guidelines"   2011
  • "A retrospective case control study of recombinant factor VIIa in patients with intracranial haemorrhage caused by trauma" British Journal of Haematology March 2011
  • "Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke" Diagnostic Molecular Pathology March 1999
  • "Heparins and heparin–induced thrombocytopenia"  January 1 2015
  • "Warfarin"  January 1 2015
  • "Moderate hypoxia suppresses exercise induced procoagulant changes and induces fibrinolysis" Blood  2000
  • "A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancer" Prostaglandins and Other Lipid Mediators January 2005
  • "Mitral valve replacement. A 10 year followup of non cloth covered vs cloth covered caged ball prostheses" Circulation  1976
  • "Randomised controlled trial" Evidence-Based Medicine  2014
  • "Drug-induced immune hematologic disease" Immunology and Allergy Clinics of North America  1998
  • "Update in hematology" Annals of Internal Medicine November 20 2007
  • "Cryopreserved deglycerolized blood is safe and achieves superior tissue oxygenation compared with refrigerated red blood cells" Journal of Trauma and Acute Care Surgery February 2013
  • "Commentary" Annals of Internal Medicine  2013
  • "Bleeding disorders"  January 1 2015
  • "Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole" Breast Cancer Research and Treatment October 2006
  • "Commentary" Evidence-Based Medicine  2001
  • "Bleeding and thrombosis"  January 1 2015
  • "Homozygous hereditary resistance to activated protein C presenting as cerebral venous thrombosis" Journal of Stroke and Cerebrovascular Diseases July 1997
  • "Thrombotic microangiopathy (TTP/HUS)"  January 1 2015
  • "Transfusion therapy and massive transfusions"  January 1 2015
  • "Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women" American Journal of Clinical Nutrition August 1999
  • "The Starr-Edwards model 6000 valve. A fifteen-year follow-up of the first successful mitral prosthesis" Circulation  1977
  • "Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis" Journal of Vascular Surgery March 2012
  • "Concurrent chemoenhancement with buslsulfoxamtne of intracarotid akylators and protection from chemotherapy-induced bone marrow toxicity with aortic thiol infusion in a rat model" Blood  2000
  • "A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer" Journal of Immunology  1992
  • "Paroxysmal nocturnal hemoglobinuria" Annals of Vascular Surgery January 2014
  • "Bleeding and thrombosis in acute promyelocytic leukemia" American Journal of Hematology June 2012
  • "Antiphospholipid antibody syndrome"  January 1 2015
  • "Thrombosis in unusual sites"  January 1 2015
  • "Antiplatelet agents"  January 1 2015

Additional information

Edit profile